Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mulders

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Peerj|November 26, 2020
Machine learning prediction of motor response after deep brain stimulation in Parkinson's disease-proof of principle in a retrospective cohortJeroen G V Habets, Marcus L F Janssen, Annelien A Duits, et al.
Neuromodulation : Journal of the International Neuromodulation Society|February 7, 2022
Cognitive Outcome After Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: A Systematic ReviewTim A M Bouwens van der Vlis, Annelien Duits, Mégan M G H van de Veerdonk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2021
Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled TrialAnja J H Moonen, Anne E P Mulders, Luc Defebvre, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Precancerous lesions in the kidneyH Van Poppel, S Nilsson, F Algaba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2013
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiNB Melichar, S Bracarda, V Matveev, et al.
Brain Stimulation|August 9, 2022
Multimodal multi-center analysis of electroconvulsive therapy effects in depression: Brainwide gray matter increase without functional changesL A van de Mortel, W B Bruin, R M Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical reportM Marchand, C J A Punt, S Aamdal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†A Kramar, S Negrier, R Sylvester, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Peerj|November 26, 2020
Machine learning prediction of motor response after deep brain stimulation in Parkinson's disease-proof of principle in a retrospective cohortJeroen G V Habets, Marcus L F Janssen, Annelien A Duits, et al.
Neuromodulation : Journal of the International Neuromodulation Society|February 7, 2022
Cognitive Outcome After Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: A Systematic ReviewTim A M Bouwens van der Vlis, Annelien Duits, Mégan M G H van de Veerdonk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2021
Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled TrialAnja J H Moonen, Anne E P Mulders, Luc Defebvre, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Precancerous lesions in the kidneyH Van Poppel, S Nilsson, F Algaba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2013
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiNB Melichar, S Bracarda, V Matveev, et al.
Brain Stimulation|August 9, 2022
Multimodal multi-center analysis of electroconvulsive therapy effects in depression: Brainwide gray matter increase without functional changesL A van de Mortel, W B Bruin, R M Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical reportM Marchand, C J A Punt, S Aamdal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†A Kramar, S Negrier, R Sylvester, et al.
Pageof 3